| Regulation of Appetite and Obesity | Lifetime | 2 | US 1 | 99.93 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 6 | US 5 | 99.93 |
| Adipose Tissue and Metabolism | Lifetime | 12 | US 9 | 99.93 |
| Biochemical Analysis and Sensing Techniques | Lifetime | 12 | US 6 | 99.79 |
| Biomarkers in Disease Mechanisms | Lifetime | 4 | US 1 | 99.59 |
| Cardiovascular Disease and Adiposity | Lifetime | 70 | US 46 | 99.53 |
| Liver Disease Diagnosis and Treatment | Lifetime | 347 | US 128 | 99.48 |
| Cancer, Lipids, and Metabolism | Lifetime | 145 | US 81 | 99.30 |
| Diet and metabolism studies | Lifetime | 317 | US 136 | 99.33 |
| Diet, Metabolism, and Disease | Lifetime | 120 | US 55 | 99.14 |
| Dietary Effects on Health | Lifetime | 32 | US 17 | 98.91 |
| Metabolism, Diabetes, and Cancer | Lifetime | 180 | US 80 | 99.16 |
| Lipid metabolism and disorders | Lifetime | 72 | US 31 | 98.89 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 216 | US 92 | 98.72 |
| COVID-19 Clinical Research Studies | Lifetime | 980 | US 229 | 96.84 |
| Diabetes Treatment and Management | Lifetime | 581 | US 215 | 97.95 |
| Birth, Development, and Health | Lifetime | 999 | US 382 | 97.56 |
| HIV-related health complications and treatments | Lifetime | 280 | US 162 | 97.63 |
| Diabetes and associated disorders | Lifetime | 784 | US 304 | 97.30 |
| Nutritional Studies and Diet | Lifetime | 739 | US 292 | 97.67 |
| Cancer Risks and Factors | Lifetime | 367 | US 191 | 97.52 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 600 | US 272 | 96.26 |
| Pharmacology and Obesity Treatment | Lifetime | 305 | US 138 | 96.60 |
| Nuts composition and effects | Lifetime | 371 | US 104 | 91.81 |
| Coffee research and impacts | Lifetime | 458 | US 76 | 90.07 |
| GDF15 and Related Biomarkers | Lifetime | 309 | US 113 | 86.94 |
| Apelin-related biomedical research | Lifetime | 990 | US 272 | 82.92 |
| Clusterin in disease pathology | Lifetime | 762 | US 163 | 50.77 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 99 | US 30 | 99.46 |
| Diet and metabolism studies | 2021-2025 | 84 | US 24 | 98.80 |
| Regulation of Appetite and Obesity | 2021-2025 | 19 | US 4 | 97.71 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 112 | US 27 | 97.01 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 65 | US 15 | 94.33 |
| Diet, Metabolism, and Disease | 2021-2025 | 86 | US 18 | 97.35 |
| Nutrition and Health in Aging | 2021-2025 | 281 | US 42 | 96.58 |
| Pharmacology and Obesity Treatment | 2021-2025 | 42 | US 20 | 96.19 |
| GDF15 and Related Biomarkers | 2021-2025 | 34 | US 9 | 90.28 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 252 | US 68 | 94.01 |
| Diabetes Treatment and Management | 2021-2025 | 508 | US 183 | 94.71 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 316 | US 86 | 91.09 |
| Pancreatic function and diabetes | 2021-2025 | 566 | US 199 | 91.43 |
| Fibroblast Growth Factor Research | 2021-2025 | 107 | US 40 | 87.29 |
| Adipose Tissue and Metabolism | 2021-2025 | 939 | US 252 | 87.15 |
| Lipid metabolism and disorders | 2021-2025 | 167 | US 45 | 85.06 |
| Liver Diseases and Immunity | 2021-2025 | 412 | US 102 | 86.89 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 798 | US 229 | 87.49 |
| Bariatric Surgery and Outcomes | 2021-2025 | 680 | US 199 | 85.14 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 938 | US 231 | 81.48 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 609 | US 134 | 81.43 |
| Kruppel-like factors research | 2021-2025 | 218 | US 58 | 76.22 |
| TGF-β signaling in diseases | 2021-2025 | 214 | US 45 | 58.81 |
